Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1979 Feb;39(2):168–174. doi: 10.1038/bjc.1979.27

Three years' experience with Ch1VPP (a combination of drugs of low toxicity) for the treatment of Hodgkin's disease.

S B Kaye, C A Juttner, I E Smith, A Barrett, D E Austin, M J Peckham, T J McElwain
PMCID: PMC2009850  PMID: 435366

Abstract

In 3 years, 118 patients with Hodgkin's disease have completed chemotherapy with chlorambucil, vinblastine, procarbazine and prednisolone (Ch1VPP). The complete remission rates were 90% for 29 patients previously treated with radiotherapy, 67% for 73 patients previously untreated and 44% for 16 patients with prior chemotherapy. The 3-year survival rates for the first 70 patients in the series were 83% for previously irradiated patients, 84% for previously untreated patients and 67% for those with prior chemotherapy. Forty-seven previously untreated or previously irradiated patients in this group achieved complete remission. The 3-year disease-free survival rates for these patients were 71% and 67% respectively. This regimen gives complete remission and survival rates comparable with results obtained with combinations including nitrogen mustard, while producing fewer side-effects.

Full text

PDF
168

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Canellos G. P., Arseneau J. C., DeVita V. T., Whang-Peng J., Johnson R. E. Second malignancies complicating Hodgkin's disease in remission. Lancet. 1975 Apr 26;1(7913):947–949. doi: 10.1016/s0140-6736(75)92007-3. [DOI] [PubMed] [Google Scholar]
  2. Carbone P. P., Kaplan H. S., Musshoff K., Smithers D. W., Tubiana M. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res. 1971 Nov;31(11):1860–1861. [PubMed] [Google Scholar]
  3. Devita V. T., Jr, Serpick A. A., Carbone P. P. Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med. 1970 Dec;73(6):881–895. doi: 10.7326/0003-4819-73-6-881. [DOI] [PubMed] [Google Scholar]
  4. McElwain T. J., Toy J., Smith E., Peckham M. J., Austin D. E. A combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's disease. Br J Cancer. 1977 Aug;36(2):276–280. doi: 10.1038/bjc.1977.187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. McElwain T. J., Wrigley P. F., Hunter A., Crowther D., Malpas J. S., Peckham M. J., Smithers D. W., Fairley G. H. Combination chemotherapy in advanced and recurrent Hodgkin's disease. Natl Cancer Inst Monogr. 1973 May;36:395–402. [PubMed] [Google Scholar]
  6. Nison D. W., Aisenberg A. C. Combination chemotherapy of Hodgkin's disease. Cancer. 1974 Jun;33(6):1499–1504. doi: 10.1002/1097-0142(197406)33:6<1499::aid-cncr2820330605>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  7. Peckham M. J., Ford H. T., McElwain T. J., Harmer C. L., Atkinson K., Austin D. E. The results of radiotherapy for Hodgkins' disease. Br J Cancer. 1975 Sep;32(3):391–400. doi: 10.1038/bjc.1975.239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Sutcliffe S. B., Wrigley P. F., Peto J., Lister T. A., Stansfeld A. G., Whitehouse J. M., Crowther D., Malpas J. S. MVPP chemotherapy regimen for advanced Hodgkin's disease. Br Med J. 1978 Mar 18;1(6114):679–683. doi: 10.1136/bmj.1.6114.679. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES